JUL 14, 2020 7:00 AM PDT

Cancer Genomics: What We Can Learn from Africa

Speaker
  • Vincent L. Gregory, Jr. Professor of Cancer Prevention, Harvard TH Chan School of Public Health and Division of Population Sciences, Dana Farber Cancer Institute
    BIOGRAPHY

Abstract
DATE:  July 14, 2020
TIME:   7:00 am PDT, 10:00 am EDT
 
This is the second topic in the webinar series on ‘Predictive Genomics for Population & Personalized Health’.
 
Cancer is a growing burden in Africa.  By 2040, it is estimated that cancer incidence will more than double in Sub-Saharan Africa, and that more than twice as many cancer deaths will occur in low- and middle-income countries compared to upper-income countries.  While the majority of cancer cases in the US and Europe are diagnosed at an early (treatable) stage, the majority of African cancer cases are and will likely continue to be diagnosed at late (often untreatable) stages.  Therefore, cancer represents a significant and under-appreciated public health problem in Africa.  We have developed the Men of African Descent and Carcinoma of the Prostate (MADCaP, www.madcapnetwork.org) to address this emerging public health issue.  MADCaP is undertaking research to 1) evaluate African ancestral relationships among African populations, 2) understand the relationship of ancestry with cancer etiology, and 3) understand the role of genetic and non-genetic factors in cancer etiology and aggressiveness.  We have established the laboratory, clinical, and epidemiological infrastructure to undertake these studies.  We have demonstrated that ancestry and candidate genes are associated with genetic susceptibility to cancer.  Therefore, optimal prediction of cancer risk and outcomes may require race-specific marker panels including polygenic risk scores. By expanding the research infrastructure and capabilities of these consortia, we will address an important and increasing cancer problem in Africa, and we will build capacity for research in an underserved continent. In addition, the increase in knowledge about genomic diversity will inform cancer risk, prevention, and treatment for all populations. 
 
Learning Objectives:
  • Review the role of genetic and non-genetic factors in cancer etiology and aggressiveness
  • Design content modules in a population-specific array
  • Develop polygenic risk scores (PRS) for a specific disease in a specific population
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

 


Show Resources
You May Also Like
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 28, 2022 6:45 AM PDT
JUN 28, 2022 6:45 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
Loading Comments...
Show Resources